Trulieve's upcoming NYSE listing follows the Trump administration's decision to reclassify medical marijuana under federal law.
A.J. Herrington is a Freelance Writer at various publications including Forbes and High Times. He covers a range of topics centered around cannabis and psychedelics, with a focus on cannabis business, regulation, and beverage production. A.J. has been featured in Cannabis Now, Forbes, Yahoo Finance, and High Times.















